CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, F.
Right arrow Articles by Amaha, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, F.
Right arrow Articles by Amaha, K.
Related Collections
Right arrow General Anesthesia
Canadian Journal of Anesthesia 47:800-806 (2000)
© Canadian Anesthesiologists' Society, 2000

Laboratory Investigations

Midazolam and ketamine inhibit glutamate release via a cloned human brain glutamate transporter

Fumio Sakai , PhD and Keisuke Amaha, PhD MD

From the Department of Anesthesiology and Critical Care Medicine, Tokyo Medical and Dental, University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo, 113-8519 Japan.

Address correspondence to: Address correspondence to: Dr. F. Sakai. Phone: 81-3-5803-5325; Fax: 81-3-5803-0149; E-mail: sakai.mane{at}med.tmd.ac.jp

Purpose: In cerebral ischemia/anoxia, the glutamate transporter runs in reverse and releases glutamate into the extracellular space, causing irreversible neuronal damage. Intravenous anesthetics attenuate overall glutamate release and prevent neuronal injury during anoxia/ischemia, but their effect on the glutamate transporter is variable.

Methods: A human glial glutamate transporter (hGLT-1) cDNA was isolated by screening a human cerebral cortical library. Cloned cDNA was transfected in Chinese hamster ovary cells. The effect of the intravenous anesthetics midazolam (0.3 to 30 µM), ketamine (10 to 100 µM), thiopental (30 to 300 µM), and propofol (3 to 30 µM) on reversed uptake of Lglutamate via hGLT-1 was examined by whole-cell patch-clamp.

Results: Midazolam at a concentration 3 µM reduced outward currents arising from reversed L-glutamate uptake via hGLT-1 in a concentration-dependent manner. While, ketamine at 100 µM attenuated the same outward currents, to 53.3 ± 11.4% of those seen in controls without anesthetics (P < 0.05, n=5). In contrast, neither thiopental nor propofol showed effects on outward currents mediated by reversed operation of hGLT-1.

Conclusions: These results suggest that midazolam and ketamine, but not thiopental and propofol, have a capacity to inhibit glutamate release via GLT-1 directly.




This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
D. A.E. Shephard
The changing pattern of anesthesia, 1954-2004: a review based on the content of the Canadian Journal of Anesthesia in its first half-century: [La transformation du modele de l'anesthesie, 1954-2004 : une revue fondee sur le contenu du premier demi-siecle du Journal canadien d'anesthesie]
Can J Anesth, March 1, 2005; 52(3): 238 - 248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Canadian Anesthesiologists' Society.